Literature DB >> 22845323

Influence of vaccination with CVI988/Rispens on load and replication of a very virulent Marek's disease virus strain in feathers of chickens.

Kamran Haq1, Thomas Fear, Abdelhakeem Ibraheem, Mohamed Faizal Abdul-Careem, Shayan Sharif.   

Abstract

Several highly efficacious vaccines are currently available for control of Marek's disease, a lymphoproliferative disease in chickens. However, these vaccines are unable to prevent infection with Marek's disease virus (MDV) in vaccinated birds. This leads to shedding of virulent MDV from feather follicle epithelium and skin epithelial cells of vaccinated and infected chickens. The objective of the present study was to study the interactions between a vaccine strain (CVI988/Rispens) and a very virulent strain of MDV (RB1B) in feathers. We examined genome load and replication of CVI988 and MDV-RB1B strains at various time points post infection. Moreover, we evaluated cytokine expression in feathers as indicators of immunity generated in response to vaccines against MDV. Analysis of feathers collected between 4 and 21 days post infection (d.p.i.) revealed a steady level of CVI988 genome load in the presence or absence of RB1B. Infection with MDV resulted in a significant increase in RB1B genome load peaking at 14 d.p.i. Importantly, vaccination with CVI988 resulted in a significant reduction in accumulation of MDV-RB1B in feathers. RB1B genome accumulation in feather tips was associated with increased expression of interferon-α at 14 d.p.i. and interferon-Sγ at earlier time points, 4 and 7 d.p.i. compared with 10 and 14 d.p.i. Interleukin-10 and interleukin-6 were up-regulated at 14 d.p.i. in the infected groups. This study expands our understanding of the dynamics of replication of vaccine and virulent MDV strains in the feathers and illuminates mechanisms associated with immunity to Marek's disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22845323     DOI: 10.1080/03079457.2011.640304

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  5 in total

1.  Molecular and pathogenicity characterization of Gallid herpesvirus 2 newly isolated in China from 2009 to 2013.

Authors:  Yan-Ping Zhang; Hong-Chao Lv; Ke-Yan Bao; Yu-Long Gao; Hong-Lei Gao; Xiao- le Qi; Hong-Yu Cui; Yong-Qiang Wang; Kai Li; Li Gao; Xiao-Mei Wang; Chang-Jun Liu
Journal:  Virus Genes       Date:  2015-11-26       Impact factor: 2.332

2.  The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek's disease vaccine.

Authors:  Jegarubee Bavananthasivam; Leah Read; Jake Astill; Alexander Yitbarek; Tamiru N Alkie; Mohamed Faizal Abdul-Careem; Sarah K Wootton; Shahriar Behboudi; Shayan Sharif
Journal:  Sci Rep       Date:  2018-11-06       Impact factor: 4.379

Review 3.  Marek's disease virus and skin interactions.

Authors:  Mathilde Couteaudier; Caroline Denesvre
Journal:  Vet Res       Date:  2014-04-03       Impact factor: 3.683

4.  Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.

Authors:  Susan J Baigent; Venugopal K Nair; Hervé Le Galludec
Journal:  J Virol Methods       Date:  2016-03-10       Impact factor: 2.014

5.  The Regulatory Microenvironment in Feathers of Chickens Infected with Very Virulent Marek's Disease Virus.

Authors:  Jegarubee Bavananthasivam; Nadiyah Alqazlan; Mohammadali Alizadeh; Ayumi Matsuyama-Kato; Jake Astill; Raveendra R Kulkarni; Shayan Sharif
Journal:  Viruses       Date:  2022-01-09       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.